Pain, Postoperative
Conditions
Interventions
The objective is to compare the effectiveness of preemptive analgesia protocols in periodontal flap surgeries and surgeries for placement of dental implants. For periodontal surgeries, there will be 2
group 2 will use 600 milligrams of ibuprofen
group 3 will use 100 milligram ketoprofen
group 4 will use 100 milligram nimesulide
group 5 will use 4 milligram dexamethasone and group 6 will use placebo, which will consist of a capsule containing corn starch. The method for electing the patient who will receive the drug will be r
E03.091
E06.892
Sponsors
Faculdade de Odontologia da Universidade Federal de Minas Gerais
Faculdade de Odontologia da Universidade Federal de Minas Gerais
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: For periodontal surgeries patients with periodontitis and need for open flap periodontal surgery for scaling and root planing; patients with good systemic health ASA I or II who do not make continuous use of any analgesic and anti-inflammatory medication could bring some kind of bias to the study outcomes; patients with absence of pain; for dental implant surgeries patients with need of bone-integrated dental implant diameter 3.5 mm or 3.75 mm height 10 or 13 mm with the site presenting 2 mm of keratinized gingiva and 10 mm of vertical bone and more than 5 mm of vestibular-lingual bone; patients with good systemic health ASA I or II who do not make continuous use of any analgesic and anti-inflammatory medication that could bring some kind of bias to the study outcomes; patients with absence of pain and signs of oral infection.
Exclusion criteria
Exclusion criteria: Pregnant or lactating mothers; asthmatics; history of allergy or intolerance to the drugs and other substances or materials used in the present research; patients with a history of kidney or liver problems; patients with blood dyscrasias; history of the use of drugs with analgesic or anti-inflammatory properties within 7 days before surgery; patients taking bisphosphonates and other anti-resorptive agents; cases in which the duration of the surgery or number of anesthetics exceeds the average time that will be standardized, trans or postoperative complications; patients who do not respond to the questionnaires.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected Outcome 1 decrease in postoperative pain; verification performed through the visual analogue scale (VAS) numbered from 0 to 10, where 0 means no pain and 10, maximum pain; evaluation performed at 1 hour, 6 hours, 24 hours, 48 hours and 72 hours after the end of the surgical procedure; a comparison will be made between the average pain of each group for each hour with a significance level of 5%. | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected outcome 2 decreased use of analgesic medication in the postoperative period; verified through the number of analgesic pills used by patients within a maximum period of 72 hours after the end of the surgical procedure. | — |
Countries
Brazil
Contacts
Public ContactLuís Cota
Faculdade de Odontologia da Universidade Federal de Minas Gerais
Outcome results
None listed